DistributionCompany
The Harvard Drug Group M&A Summary
The Harvard Drug Group has acquired 2 companies of its own. It has also divested 1 asset.
The Harvard Drug Group’s largest acquisition to date was in 2012, when it acquired The Rugby Group for $117M. It’s largest disclosed sale occurred in 2022, when it sold Letco Medical to Fagron NV for $34M. The Harvard Drug Group has acquired in 2 different US states. The Company’s most targeted sectors include distribution (50%) and medical products (50%).
The Harvard Drug Group Ownership
Who owns The Harvard Drug Group?
The Harvard Drug Group is owned by Cardinal Health. It was acquired on June 5, 2015.
Was The Harvard Drug Group formerly PE-backed?
Yes. The Harvard Drug Group was formerly owned by 2 private investors.
The Harvard Drug Group Business Overview
Where is The Harvard Drug Group headquartered?
The Harvard Drug Group is headquartered in Livonia, Michigan.
What sector is The Harvard Drug Group in?
The Harvard Drug Group is a distribution company.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity2
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
Unlimited Searches
